Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for GLYBURIDE
- Investigation of the Efficacy of Metformin Therapy on Pulmonary Sarcoidosis
- Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
- Spinal Cord Injury Neuroprotection With Glyburide
- Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction
- Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult Volunteers
- Gestational Diabetes and Pharmacotherapy (GAP)
- Safinamide Steady State Interaction With Rosuvastatin
- Randomization of Early Diabetes Screening Among Obese Pregnant Women.
- Failure Rate of GLyburide And Metformin Among Gestational Diabetics
- Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus
- Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction
- The Drug -Drug Interaction of SP2086 and Glyburide
- Glyburide vs Glucovance in the Treatment of GDM
- Spinal Cord Injury Neuroprotection With Glyburide
- Drug Interaction Study of Safinamide and a BCRP Substrate, Diclofenac, Concomitantly Administered to Healthy Volunteers
- Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593)
- Bioavailability of BI 1356 and Glyburide in Healthy Male and Female Volunteers
- Oral Antidiabetic Agents in Pregnancy
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Glyburide and Metformin for the Treatment of Gestational Diabetes Mellitus. Systematic Review
- Glycemic Profile in Women With Gestational Diabetes Treated With Glyburide
- Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes
- Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
- A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics, Pharmacodynamics, and Safety of Glyburide in Healthy Volunteers
- Multicenter Randomized Trial of Non-inferiority Between Glyburide and Insulin for the Treatment of Gestational Diabetes
- Glyburide Healthy Volunteer Study
- A Study to Evaluate the Efficacy and Safety of BRL 49653C in Non-insulin Dependent Diabetes
- Efficacy of Repaglinide in Subjects With Type 2 Diabetes
- Effect of Repaglinide on Postprandial Lipemia in Type 2 Diabetes
- R230C and C230C Variants of ABCA1 and Glyburide Response
- Glyburide (RP-1127) for Traumatic Brain Injury (TBI)
- Glyburide and Metformin for Gestational Diabetes Mellitus (GDM)
- Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus
- Effects of Saxagliptin on Endothelial Function
- Glyburide Advantage in Malignant Edema and Stroke Pilot
- Gestational Diabetes: Insulin or Oral Hypoglycemic Agents?
- Safety Study of RP-1127 (Glyburide for Injection) in Healthy Volunteers
- To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies
- Fracture Risk With Thiazolidinediones
- A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus
- Metformin Compared to Glyburide in Gestational Diabetes
- Interplay Between Organic Anion Transporting Polypeptide (OATP) Transporters Transporters and CYP2C9 in Glyburide Pharmacokinetics (PK)
- A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting Conditions
- A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting Conditions
- A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Non-fasting Conditions
- Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fasting
- Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fed
- Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL)
- Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus.
- Treatment of Mild Gestational Diabetes With Glyburide Versus Placebo
- Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia
- Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
- Effect of Rosiglitazone on Myocardial Blood Flow Regulation in Type 2 Diabetes
- Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart Failure
- Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease
- Rosiglitazone on Microalbuminuria in Type 2 Diabetics
- Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study
- Safety Study of Pioglitazone Compared To Glyburide on Liver Function
- Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subjects With Type 2 Diabetes
- A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.
- Comparison of Glucovance to Insulin for Diabetes During Pregnancy
- Insulin Glargine in Type 2 Diabetic Patients
- AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide Alone
- A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas
- Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.
- Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
- Preservation of Beta-cell Function in Type 2 Diabetes Mellitus
- Preferred Treatment of Type 1.5 Diabetes
- PPAR-COMBO With Sulfonylurea
- Glyburide Compared to Insulin in the Management of White's Classification A2 Gestational Diabetes
- Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic Patients
- Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment
- A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes
- A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.
Clinical trials list
click for details